Search by Drug Name or NDC

    NDC 69315-0504-47 NYSTATIN 100000 [USP'U]/mL Details

    NYSTATIN 100000 [USP'U]/mL

    NYSTATIN is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Leading Pharma, LLC. The primary component is NYSTATIN.

    Product Information

    NDC 69315-0504
    Product ID 69315-504_65730b91-5b22-4bfa-a3ca-13f12c7a2eed
    Associated GPIs
    GCN Sequence Number 009537
    GCN Sequence Number Description nystatin ORAL SUSP 100000/ML ORAL
    HIC3 W3A
    HIC3 Description ANTIFUNGAL ANTIBIOTICS
    GCN 42440
    HICL Sequence Number 004129
    HICL Sequence Number Description NYSTATIN
    Brand/Generic Generic
    Proprietary Name NYSTATIN
    Proprietary Name Suffix n/a
    Non-Proprietary Name NYSTATIN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 100000
    Active Ingredient Units [USP'U]/mL
    Substance Name NYSTATIN
    Labeler Name Leading Pharma, LLC
    Pharmaceutical Class Polyene Antifungal [EPC], Polyenes [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA214346
    Listing Certified Through 2025-12-31

    Package

    NDC 69315-0504-47 (69315050447)

    NDC Package Code 69315-504-47
    Billing NDC 69315050447
    Package 473 mL in 1 BOTTLE (69315-504-47)
    Marketing Start Date 2022-12-05
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.05231
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description NYSTATIN 100,000 UNIT/ML SUSP
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis